ולטרקס טבליות 500 מג

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Osta kohe

Infovoldik Infovoldik (PIL)
27-10-2023

Toimeaine:

VALACICLOVIR AS HYDROCHLORIDE

Saadav alates:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC kood:

J05AB11

Ravimvorm:

טבליות מצופות פילם

Koostis:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Manustamisviis:

פומי

Retsepti tüüp:

מרשם נדרש

Valmistatud:

GLAXO WELLCOME SA, SPAIN

Terapeutiline rühm:

VALACICLOVIR

Terapeutiline ala:

VALACICLOVIR

Näidustused:

Valtrex is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults.Valtrex accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established. Valtrex is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valtrex is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Toote kokkuvõte:

התרופה תינתן למניעת מחלת CMV במושתלי איברים

Loa andmise kuupäev:

2021-02-28

Infovoldik

                                " (
)
-
1986
500
"
500
(
) "
VALACICLOVIR (AS HYDROCHLORIDE)
500
MG
6
.
.
.
,
.
.
.
.
1
.
?
)
HSV
) ,(
VZV
(
-
)
CMV
.(
:
•
.
•
VZV
)
ophthalmic zoster
(
.
•
)
HSV
(
)
(
.
.
•
)
HSV
. (
•
CMV
.
:
.
2
.
:
()
)
6
.(
: ,
•
.
•
.
•
65
.
•
.
-
:
)
DRESS
(
.
DRESS
,
. (
)
← ,
. , . , , .
. / , , , . ,
: .
,
,
, ,
. , , , , ,
.
,
,
,
.
.
)
.(
3
.
?
.
.
.
:
)
zoster
s
Herpe
(
•
1,000
)
"
500
,("
.
•
.
)
sores
Cold
)
(
12
(
•
2,000
) "
500
. ,("
•
12
)
6
. (
•
. (
)
HSV
)
12
(
•
500
. ,"
•
.
3
5
.
HSV
)
12
(
•
500
.
,"
•
.
CMV
)
-
)
(
12
(
•
2,000
) "
500
,("
.
•
6
.
•
.
•
90
,
.
:
•
65
.
•
.
•
.
←
.
.
:
•
.
•
.
•
.//
•
.
•
.
65
.
.
.
.
,
.
,
, , ,
. ,
,
,
,
.
, .
,
. ,
.
. ! .
.
. ,
4
.
,
.
. .
:
←
:
.
.(
)
:
•
,
•
()
, , ,
•
.
) ,
.
DRESS
(
. ,
:
)
COMMON
VERY
(
-
:
•
)
COMMON
(
-
-
10
-
1
100
:
•
•
•
•
•
(
)
•
•
)
UNCOMMON
(
-
-
10
-
1
1,000
:
•
•
()
•
•
•
,
,
,
-
8
.
.
:
•
()
•
•
, ,
(
)
•
( )
•
()
:
•
(
)
•
(
)
•
)
RE
RA
(
-
-
10
-
1
10,000
:
•
()
•
() ,
•
()
•
()
•
()
•
()
,
,
,
-
8
.
.
:
•
)
(
:
•
DRESS
,
,
,
,()
,
.
2
.
•
(tubulointerstitial nephritis) ,
. ,
"
"
)
www.health.gov.il
" ,
(
:
https://sideeffects.health.gov.il/
5
.
?
•
!
.
/
.
•
)
exp. date
(
.
.
•
-
C
30°
.
6
.
• ,
:
Microcrystalline cellulose
Crospovidone
Povidone ,K90
White Colour Concentrate YS-
18043
-
1
(Hypromellose, Titanium dioxide, Polysorbate 80, Polyethylene Glycol
400)
Magnesium stearate
Colloidal Anhydrous Silica
Carnauba wax.
•
:
.
500
"
2
,
10
42
.
-
"
GX CF1
"
.
.
•
:
S.A.
.
, ,
•
:
' ," (
)
25
. ,
•
:
100-39-28426-00
.
,
.
,
.
GSK
.
©
2023
GSK
.
2023
.
Val PT v9A
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik inglise 07-06-2023
Toote omadused Toote omadused inglise 04-04-2023
Avaliku hindamisaruande Avaliku hindamisaruande inglise 05-05-2020
Infovoldik Infovoldik araabia 07-06-2023